#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13362	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2395	683.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1899	1899	T	873	T,G,A	870,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13362	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2395	683.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1633	1633	C	884	C,T,A	882,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13362	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2395	683.1	0	HET	.	.	.	A69G,T	.	69	69	A	518	518	A	842	A,G,T	666,174,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22042	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4060	677.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1914	1914	A	914	A,C	913,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22042	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4060	677.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2548	2548	C	719	C,G,A	717,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22042	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4060	677.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2622	2622	A	669	A,C	668,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22042	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4060	677.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3174	3174	C	800	C,T,G,A	797,1,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	2020	folP	852	852	99.88	folP.l15.c4.ctg.1	2105	119.5	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1108	1110	AAA	207;204;205	A;A;A	207;204;205	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	2020	folP	852	852	99.88	folP.l15.c4.ctg.1	2105	119.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1339	1341	AGC	195;193;195	A;G;C	195;193;195	folP.WHO_X_01360c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4422	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3971	138.9	1	SNP	p	S91F	0	.	.	271	273	TCC	894	896	TCC	165;163;164	T;C;C	165;163;164	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4422	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3971	138.9	1	SNP	p	D95N	0	.	.	283	285	GAC	906	908	GAC	170;171;171	G;A;C	170;171;171	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4422	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3971	138.9	1	SNP	p	D95G	0	.	.	283	285	GAC	906	908	GAC	170;171;171	G;A;C	170;171;171	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1790	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1771	126.1	1	SNP	p	G45D	0	.	.	133	135	GGC	704	706	GGC	217;217;216	G,T;G;C	216,1;217;216	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1010	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1441	87.5	0	.	n	.	0	A197.	DEL	197	197	A	811	811	A	204	A	204	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4584	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3356	170.2	1	SNP	p	D86N	0	.	.	256	258	GAC	785	787	GAC	195;197;198	G;A;C	195;197;198	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4584	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3356	170.2	1	SNP	p	S87R	0	.	.	259	261	AGT	788	790	AGT	201;198;199	A,G;G;T	200,1;198;199	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4584	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3356	170.2	1	SNP	p	S87I	0	.	.	259	261	AGT	788	790	AGT	201;198;199	A,G;G;T	200,1;198;199	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4584	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3356	170.2	1	SNP	p	S87W	0	.	.	259	261	AGT	788	790	AGT	201;198;199	A,G;G;T	200,1;198;199	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4584	parC	2304	2304	99.91	parC.l6.c4.ctg.1	3356	170.2	1	SNP	p	S88P	0	.	.	262	264	TCC	791	793	TCC	202;202;203	T;C;C,A	202;202;202,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3844	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3163	151.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1827	1829	GGC	206;203;201	G;G;C	206;203;201	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3644	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	153.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1582	1584	GCA	194;194;195	G,A;C,T,A;A	193,1;192,1,1;195	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3644	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	153.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1585	1587	ATC	192;192;193	A;T,C;C	192;191,1;193	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3644	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	153.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1597	1599	GTG	188;188;186	G;T;G	188;188;186	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3644	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	153.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1597	1599	GTG	188;188;186	G;T;G	188;188;186	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3644	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	153.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2101	2103	ACC	203;205;207	A,T;C;C	202,1;205;207	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3644	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	153.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2155	2157	GCG	196;196;196	G;C;G	196;196;196	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3644	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	153.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2155	2157	GCG	196;196;196	G;C;G	196;196;196	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3644	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	153.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2278	2280	GGC	212;210;211	G;G,T;C	212;209,1;211	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3644	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	153.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2287	2289	GGC	216;216;213	G;G,A;C	216;215,1;213	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3644	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2955	153.9	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2305	2307	CTG	202;204;205	C,A;T;G	201,1;204;205	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5158	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3545	181.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1862	1864	CCG	217;216;213	C;C,T,A;G	217;214,1,1;213	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2122	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2271	116.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	786	786	C	146	C	146	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	236	porB1a	984	154	92.86	porB1a.l6.c4.ctg.4	154	45.0	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	25;27;27	T,G;T;A	24,1;27;27	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	236	porB1a	984	154	92.86	porB1a.l6.c4.ctg.4	154	45.0	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	55;55;55	C,T;A;T	54,1;55;55	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	236	porB1a	984	154	92.86	porB1a.l6.c4.ctg.4	154	45.0	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	55;55;55	A;G;T	55;55;55	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	236	porB1a	984	154	92.86	porB1a.l6.c4.ctg.4	154	45.0	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	55;55;55	T;A;C	55;55;55	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	236	porB1a	984	100	94.0	porB1a.l6.c4.ctg.5	181	36.6	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	36;36;36	A;C;G	36;36;36	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	236	porB1a	984	100	94.0	porB1a.l6.c4.ctg.5	181	36.6	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	8;8;8	C;A;A	8;8;8	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2556	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2052	155.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	669	671	GAA	204;204;203	G;A,C;A	204;202,1;203	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2556	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2052	155.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	957	959	GAT	229;229;229	G,A;A;T,G,C	228,1;229;227,1,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2556	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2052	155.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1080	1082	TCA	226;229;229	T,G;C;A	225,1;229;229	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2556	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2052	155.3	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1209	1211	GTC	228;226;226	G;T;C	228;226;226	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2556	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2052	155.3	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1221	1223	TCT	224;221;219	T;C;T	224;221;219	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2556	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2052	155.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1539	1541	GCA	211;209;209	G,T;C;A	210,1;209;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2556	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2052	155.3	1	SNP	p	G120K	1	.	.	358	360	AAG	915	917	AAG	229;227;228	A;A;G	229;227;228	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2556	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2052	155.3	1	SNP	p	D121N	0	.	.	361	363	GAC	918	920	GAC	225;229;227	G;A,C;C	225;228,1;227	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2556	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	2052	155.3	1	SNP	p	A121D	1	.	.	361	363	GAC	918	920	GAC	225;229;227	G;A,C;C	225;228,1;227	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	8688	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5406	200.4	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2259	2261	AAT	227;224;224	A;A;T	227;224;224	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1236	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1532	100.4	1	SNP	p	V57M	1	.	.	169	171	ATG	746	748	ATG	211;210;209	A;T;G	211;210;209	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
